Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal

BACKGROUND: Despite direct-acting antivirals (DAA), aims to “eradicate” viral hepatitis by 2030 remain unlikely. In Nepal, an expert consortium was established to treat HCV through Nepal earthquakes aftermath offering a model for HCV treatment expansion in a resource-poor setting. METHODOLOGY/PRINCI...

Descripción completa

Detalles Bibliográficos
Autores principales: KC, Sudhamshu, Murphy, Holly, Dixit, Sameer, Rai, Apurva, Pradhan, Bickram, Lagrange-Xelot, Marie, Karki, Niyanta, Dureault, Amélie, Karmacharya, Ujjwal, Panthi, Santosh, Tulachan, Nabin, KC, Prawchan, KC, Anjay, Rajbhandari, Rajesh, Trotter, Andrew B., Gölz, Jörg, Pradat, Pierre, Trépo, Christian, Creac'H, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773414/
https://www.ncbi.nlm.nih.gov/pubmed/33326423
http://dx.doi.org/10.1371/journal.pntd.0008931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773414/
https://www.ncbi.nlm.nih.gov/pubmed/33326423
http://dx.doi.org/10.1371/journal.pntd.0008931

Ejemplares similares